Pembrolizumab-associated bronchiolitis in an elderly lung cancer patient required the treatment with an inhaled corticosteroid, erythromycin and bronchodilators.
Focal lung infiltrate complicating PD-1 inhibitor use: A new pattern of drug-associated lung toxicity?
